Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (9): 31-39    DOI: 10.13523/j.cb.20140906
    
Effect of Silencing Nup88 Gene by RNA Interference on Growth and Invasion in Human Breast Cancer MCF-7 Cell
LI Yu-qiang, ZHU Zhi-tu, WANG Wei, LI Chen, XU Na, WANG Yu, LI Nan, SUN Hong-zhi
The First Affiliated Hospital of Liaoning Medcial Uinversity, Jiuzhou 121001, China
Download: HTML   PDF(1432KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: Construct recombinant lentivirus NUP88-shRNA mediated by the carrier, by RNAi technology respectively to observe silence after NUP88 MCF-7 proliferation, adhesion, invasion and metastasis of influence, looking for new targets for clinical gene therapy of breast cancer. Methods Build NUP88 Lentivirus vectors, packaging test after drop, to MOI cell transfection breast cancer MCF-7, using RT-PCR and Western-blot test each mRNA and protein expression in MCF-7 cell efficiency; Determined by MTT method and flow cytometry assay, after testing NUP88 gene is interference effects on MCF-7 cell proliferation and apoptosis; Cell invasion after experimental detection NUP88 gene is interference effects on MCF-7 aggressivity. Results Four groups of virus and a negative control group are building a successful, drop degrees are 4E+ 8 Tu/mL; RT-RCR and Western-blot test, the results show that the NUP88-shRNA transfection of MCF-7 cell group NUP88 mRNA and protein expression and the negative transfection group and blank MCF-7 cell group compared with significant difference statistically significant (P<0.01); Determination of NUP88-shRNA1 group of silence, the most efficient silence rate can reach 86%; Determined by MTT method, the results show that the experimental group after NUP88-shRNA1 Lentivirus transfection cell proliferation significantly reduced, compared with the blank group and the control group with significant difference (P<0.05); Flow cytometry instrument detection of three groups of MCF-7 cell apoptosis results show that the experimental group after lentivirus transfection cell apoptosis rate increased significantly, compared with the control group and blank group had significant difference (P<0.05); Cell invasion experiment show that the tumor cells to conventional training after 24 h, compared with the blank group and the negative control group, experimental group in membrane cells decreased significantly, with significant difference (P<0.05). Conclution NUP88 recombinant lentivirus can suppress the MCF-7 by RNAi successful NUP88 gene expression, and can significantly inhibit the proliferation and invasion ability in the distance.



Key wordsNUP88      Human breast cancer cells MCF-7      RNAi      Lentivirus vectors     
Received: 08 July 2014      Published: 25 September 2014
ZTFLH:  Q78  
Cite this article:

LI Yu-qiang, ZHU Zhi-tu, WANG Wei, LI Chen, XU Na, WANG Yu, LI Nan, SUN Hong-zhi. Effect of Silencing Nup88 Gene by RNA Interference on Growth and Invasion in Human Breast Cancer MCF-7 Cell. China Biotechnology, 2014, 34(9): 31-39.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140906     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I9/31


[1] 杨清默.CA153,CA125及CEA在乳腺癌诊断中的应用探讨.中国普通外科杂志,2011, 20(11):1265-1267.

[2] Yoo Y D, Han D H, Jang J M, et al. Molecular characteristics of cancer stem-like cells derived from human breast cancer cells. Anticancer Res, 2010, 33(3):763-77.

[3] Ozgün A, Karagoz B, Bilgi O, et al. MicroRNA-21 as an Indicator of aggressive phenotype in breast cancer. Onkologie, 2011, 36(3):115-118.

[4] Seah D S, Scott S M, Openshaw T, et al. Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol, 2012, 45(3):102-108.

[5] Bao P, Li Y, Chen K, et al. The set-u Pof an in vitro model for stable knockdown of MyD88 by lentivirus-based RNAi in IEC-6 cell line and the study on its early apoptosis Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2012, 29(6):1138-1149.

[6] Ramachandran P V, Ignacimuthu S. RNA Interference-A silent but an efficient therapeutic tool. Appl Biochem Biotechnol, 2013, 64(4):361-369.

[7] Zhao Z R, Zhang Z Y, He X Q, et al. Nup88 mRNA overexpression in colorectal cancers and relationshi Pwith p53. Cancer Biomark, 2010-2011, 8(2):73-80.

[8] Hashizume C, Nakano H, Yoshida K, et al. Characterization of the role of the tumor marker Nup88 in mitosis. Mol Cancer, 2010, 24(9):119-123.

[9] Emterling A, Skoglund J, Arbman G, et al. Clinicopathological significance of Nup88 expression in patients with colorectal cancer. Oncology, 2003, 64(4):361-369.

[10] Martínez N, Alonso A, Moragues M D, et al. The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res, 1999, 59(21):5408-5411.

[11] 田延锋,赵增仁,李芳,等.NUP88蛋白在乳腺癌中的表达及其临床意义.中国普外科杂志,2011,21(11):1146-1148.

[12] Hashizume C, Nakano H, Yoshida K, et al. Characterization of the role of the tumor marker Nup88 in mitosis. Mol Cancer, 2010, 24(9):119-123.

[13] 王鑫,陈玲,孙飞,等.RNAi沉默CXCR7对人结肠癌细胞SW620特异性靶向抑制的实验研究. 中国生物工程杂,2014, 34 (2):14-20. Wang X, Chen L,Sun F,et al.Experimental study of specific targeted inhibition from RNAi silencing CXCR7 to human colon cancer cell SW620. China Biotechnology, 2014,34(2):14-20.

[14] 陆航,刘学政,孙巨峰,等.RNA干扰沉默CXCR4基因对胃癌细胞SGC7901增殖和侵袭力的影响.中国老年学杂志,2012,13 (3):25-28.

[15] Bao P, Li Y, Chen K, et al. The set-u Pof an in vitro model for stable knockdown of MyD88 by lentivirus-based RNAi in IEC-6 cell line and the study on its early apoptosis. Journal of Biomedical Engineering, 2012, 29(6):1138-1149.

[16] Heaton M P, Kalbfleisch T S, Petrik D T, et al. Genetic Testing for TMEM154 Mutations Associated with Lentivirus Susceptibility in Sheep. International Shee PGenomics Consortium. PLoS One, 2013, 8(2):554-590.

[17] Liu C, Wang L, Li W, et al. Highly efficient generation of transgenic shee Pby lentivirus accompanying the alteration of methylation status. PLoS One, 2011, 8(1):546-614.

[18] 褚波,黄雪峰,唐云明.慢病毒载体及其应用进展.生物医学工程学杂志,2008,1 (2):18-20. Chu B, Huang X F, Tang Y M. Lentiviral vectors and advance in its application. Journal of Biomedical Engineering,2008,25(1):224-226.

[19] Jorgen sen R A, Clust er P D, English J, et al. Chalcone synthase co -suppression phenotypes in petunia flowers: comparison of sense vs. antisense constructs and single -copy vs. complex T -DNA sequences. Plant Mol Biol, 1996, 31(5):957 -973.

[20] Fire A, Xu S, Montgomery M K, et al. Potent and specific genetic interference by double -stranded RNA in Caenorhabditis elegans. Nature, 1998, 391(66):666-670.

[21] A l derton W K, Cooper C E, Know les R G. Nitric oxide synthases :structure, function and inhibition. Biochem J, 2001,357 (23): 593-615.

[22] Dudzinski D M, Igarashi J, G reif D, et al. The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol, 2006, 46: 235-276.

[23] 李玉强,王巍,胡兵兵,等.核孔蛋白复合体蛋白88在乳腺癌细胞株MCF-7和MDA-MB-435S中的表达及意义研究.临床合理用药杂志,2013,4 (6):1-3. Li Y Q,Wang W,Hu B B,et al.Research of NUP88 in breast cancer cell line MCF-7 and MDA-MB-435S the expression and significance. Clinical Rational Drug Use,2013,6(4):1-3.

[24] Agudo D,Gómez-Esquer F, Martínez-Arribas F,et al.Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer, 2004, 10(5):717-715.

[25] Schneider J,Martnez-Arribas F, Torrejon R Nup88 Expression is Associated With Myometrial Invasion in Endometrial Carcinoma J. Int J Gynecol Cancer, 2010, 12(5):804-808.

[1] LIU Li, YANG Xiao-hui, WANG Rui-ming. The Effect of KAT Gene Silencing by RNAi on the Synthesis of 10-HDA in Bees[J]. China Biotechnology, 2016, 36(4): 63-68.
[2] REN Qin, GUO Zhi-hong, WANG Ya-jun, XIE Zhong-kui, WANG Ruo-yu. RNA Interference and Its Application in Enhancing Crop Resistance Against Harmful Eukaryotes[J]. China Biotechnology, 2015, 35(6): 80-89.
[3] XUE Yu-wen, LI Tie-jun, ZHOU Jia-ming, CHEN Li. The Application and Perspectives of Multi-target RNAi in the Research and Development of Gene Therapy[J]. China Biotechnology, 2015, 35(1): 75-81.
[4] WANG Kang, HE Chun, GAO Wei, WANG Bin-quan, WANG Xiao-xia. Effect of IQGAP1 Knockdown on Homotypic Cell-Cell Adhesion of Esophageal Carcinoma Cells[J]. China Biotechnology, 2014, 34(9): 24-30.
[5] JIANG Ting-ting, WEN Xiao-xia, CHEN Yao. Effect of Silencing c2orf68 Gene on the Proliferation of Colorectal Adenocarcinoma Cells[J]. China Biotechnology, 2014, 34(2): 7-13.
[6] WANG Xin, CHEN Ling, SUN Fei, LU Hang. Experimental Study of Specific Targeted Inhibition from RNAi Silencing CXCR7 to Human Colon Cancer Cell SW620[J]. China Biotechnology, 2014, 34(2): 14-20.
[7] ZHU Kuan-peng, ZHAO Shu-jin. Double-stranded RNA-mediated Gene Silencing and Over-expression of FmSTS in Polygonum multiflorum Thunb Hairy Roots[J]. China Biotechnology, 2012, 32(08): 41-48.
[8] TANG De-ping, MAO Ai-hong, LIAO Shi-qi, XUE Lin-gui, ZHANG Bing-lin. The Types of siRNA Off-target Effects and the Strategies for Mitigation[J]. China Biotechnology, 2012, 32(07): 113-119.
[9] ZHAO Rui, LV Jing-ye, HUANG Hai-li, YAN Qi-tao. Construction of Recombinant Lentiviral Vector of shRNA for CHD5 Gene and the Study of Its Functions in Human Colon Carcinoma Lovo Cells[J]. China Biotechnology, 2012, 32(05): 7-11.
[10] LI Pei-pei, YOU Lei-ming, LOU Jun, E Wei, JIANG Zhi-zheng, ZHI Yu-bao, ZHANG Gai-ping, WANG Ai-ping. A Dual-marker Vector for Constant RNAi and Rapid Selection of Stable RNAi Clones in Gallus Cells[J]. China Biotechnology, 2011, 31(11): 81-89.
[11] . [J]. China Biotechnology, 2011, 31(03): 124-127.
[12] XIE Mei-Xia, LIU Jun-Mei, LI Hao, CUI Dong-Qing, WANG Jing-Cheng, ZHANG Zhi-Yi, AN Xin-Min. amiRNAi: A New Approach for Highly Specific and Stable Gene Silencing[J]. China Biotechnology, 2010, 30(08): 118-125.
[13] XU Liang, GU Yu-Chao, SHI Han, FU Wen-Xi, XU Wen-Gong. STAT3 Silencing Inhibits Migration of Murine Breast Cancer Cells in vitro[J]. China Biotechnology, 2010, 30(06): 1-7.
[14] GUO Rui, LI Chi-Xia, JIE Jun. Inhibition of Proto-oncogene Pokemon Expression by siRNA Expression Vector in SW480 Cells[J]. China Biotechnology, 2009, 29(06): 7-13.
[15] RUAN Jing-ling ZHEN-xin . Myostatin inhibits myogenic satellite cell differentiation through down-regulating MyoD expression by Smad3[J]. China Biotechnology, 2008, 28(5): 99-103.